Increased immunoaccessibility of MOMP epitopes in a vaccine formulated with amphipols may account for the very robust protection elicited against a vaginal challenge with Chlamydia muridarum.
about
A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challengeLong-term stability of a vaccine formulated with the amphipol-trapped major outer membrane protein from Chlamydia trachomatisLabeling and functionalizing amphipols for biological applications.Synthesis of an oligonucleotide-derivatized amphipol and its use to trap and immobilize membrane proteinsChlamydial protease-like activity factor mediated protection against C. trachomatis in guinea pigsImmunization of a wild koala population with a recombinant Chlamydia pecorum Major Outer Membrane Protein (MOMP) or Polymorphic Membrane Protein (PMP) based vaccine: New insights into immune response, protection and clearanceIn vivo characterization of the biodistribution profile of amphipol A8-35Amphipols for each season.Cell-free production of a functional oligomeric form of a chlamydia major outer membrane protein (MOMP) for vaccine development.Comparison of the nine polymorphic membrane proteins of Chlamydia trachomatis for their ability to induce protective immune responses in mice against a C. muridarum challenge.Update on Chlamydia trachomatis Vaccinology.B cell presentation of Chlamydia antigen selects out protective CD4γ13 T cells; implications for genital tract tissue resident memory lymphocyte clusters.Amphipols and photosynthetic light-harvesting pigment-protein complexes.Spectroscopic Analysis of Chlamydial Major Outer Membrane Protein in Support of Structure ElucidationThe M278 Major Outer Membrane Peptide Encapsulated in the Poly(lactic acid)-Poly(ethylene glycol) Nanoparticulate Self-Adjuvanting Delivery System Protects Mice Against a Genital Tract Challenge by Stimulating Robust Systemic and Local Mucosal Immune
P2860
Q28391567-C67A579F-8D06-4AD2-9A6F-DD2FF21E0A0FQ30363742-84302C30-3FEF-4060-A482-40557A6E8CBAQ30792341-2047C548-A220-4751-92EF-C8645B27F073Q33698501-AE2D1256-7A1F-415E-8E4B-BB3DB61318B0Q33740057-F309661B-FBDA-475A-9175-54EB47ACC968Q33757880-062D318C-CDE8-4354-A195-1E4AA0D7C01FQ34345353-5772DFBB-1F40-45C0-8B09-9CFC4CEC5CE3Q34803829-144D6BCE-544D-46E2-99F7-EB5DE45A31C4Q37833759-EEB6E537-61AD-4641-BC2D-52C3BF98294DQ37834482-B2955577-030F-485E-A523-E302529F2FC4Q37834874-5314D423-25AF-4874-9011-31A08DA1A3AFQ44059377-1F9AE436-58F8-4555-A87B-34AF1245637AQ50451500-A5CC150C-489F-4F1F-BA9C-0339F6C596CDQ57751827-96ACC7ED-4E7A-4ECF-B451-525ECAB47011Q58122056-E4EB209F-D4DB-4095-9EAE-2B93F30985D0
P2860
Increased immunoaccessibility of MOMP epitopes in a vaccine formulated with amphipols may account for the very robust protection elicited against a vaginal challenge with Chlamydia muridarum.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Increased immunoaccessibility ...... enge with Chlamydia muridarum.
@ast
Increased immunoaccessibility ...... enge with Chlamydia muridarum.
@en
type
label
Increased immunoaccessibility ...... enge with Chlamydia muridarum.
@ast
Increased immunoaccessibility ...... enge with Chlamydia muridarum.
@en
prefLabel
Increased immunoaccessibility ...... enge with Chlamydia muridarum.
@ast
Increased immunoaccessibility ...... enge with Chlamydia muridarum.
@en
P2093
P2860
P356
P1476
Increased immunoaccessibility ...... enge with Chlamydia muridarum.
@en
P2093
Delia F Tifrea
Jean-Luc Popot
Luis M de la Maza
Melanie J Cocco
Sukumar Pal
P2860
P304
P356
10.4049/JIMMUNOL.1303392
P407
P577
2014-04-28T00:00:00Z